MPT Product Development Database

This database includes MPT products that are currently available, as well as MPT products in active development. In addition, a number of existing products and products in development for single indications are also included. The database outlines detailed product information and can be searched to display products by desired criteria as selected from the drop-down boxes or by entering a keyword in the search box. Click on the product name to access detailed information on each product. Click here to learn more about the inclusion criteria and information update methodology.

Links to Summary Tables outlining (1) MPT Products in Development, (2) Existing Single Indication Products or (3) Candidate Single Indication Products that could serve as potential components of future MPTs can be found below.
Help us keep the database complete and up to date!
If you know of an MPT product not included in the database or have updated information for listed products, please contact us using the “MPT Database Feedback” form.
Check out the MPT products in the development pipeline – view an MPT Pipeline Table by Indication Combination.
Product TypeDelivery RouteDelivery MethodDevelopment Stage
       
IndicationProduct DeveloperProduct Sponsor/FundingActive Ingredient
       
Key Word Search   
       

23 product(s) found

Results: 25 product(s) found
Product Name
Product Type
Delivery Route
Delivery Method
Active Ingredient
Developer
Stage
Indication(s)
Amphora Gel MPT in Development Topical Gel-Vaginal
  • Acidform
  • Evofem Inc.
  • C1
  • Chlamydia
  • Gonorrhea
  • Pregnancy
  • BioRings TM IVR MPT in Development Topical Intravaginal Ring (IVR)
  • Ascorbic Acid
  • Boc-Lysinated Betulonic Acid
  • Ferrous Gluconate
  • Polyamino-Polycarboxlic Acid
  • Tenofovir (TFV)
  • BioRings LLC
  • P1
  • HIV
  • Pregnancy
  • Dapivirine + Levonorgestrel IVR MPT in Development Topical Intravaginal Ring (IVR)
  • Dapivirine
  • Levonorgestrel
  • International Partnership for Microbicides (IPM)
  • P2
  • HIV
  • Pregnancy
  • Griffithsin (GRFT) fast dissolve vaginal insert (FDI) [PC-9500] MPT in Development Topical Fast Dissolve Insert/Capsule-Vaginal
  • Griffithsin (GRFT)
  • PATH
  • Population Council
  • P1
  • HIV
  • HPV
  • HSV-2
  • Griffithsin (GRFT) in Carrageenan gel (PC-6500) MPT in Development Topical Gel-Vaginal
  • Griffithsin (GRFT)
  • Population Council
  • P2
  • HIV
  • HPV
  • HSV-2
  • Griffithsin (GRFT) IVR (PC-7500) MPT in Development Topical Intravaginal Ring (IVR)
  • Griffithsin (GRFT)
  • Population Council
  • P1
  • HIV
  • HPV
  • HSV-2
  • Griffithsin Gel MPT in Development Topical Gel-Rectal
  • Griffithsin (GRFT)
  • University of Louisville
  • P1
  • Chlamydia
  • HIV
  • HSV-2
  • HER102 MPT in Development Topical Fast Dissolve Insert/Capsule-Vaginal
  • Lactobacillus
  • Other
  • P1
  • Gonorrhea
  • Pregnancy
  • mapp66 (mAb) Film MPT in Development Topical Film - Vaginal
  • Monoclonal Antibodies
  • Mapp Biopharmaceutical, Inc.
  • C1
  • HIV
  • HSV-2
  • MIV-150 and zinc acetate in carrageenan gel (PC-1005) MPT in Development Topical Gel-Vaginal;Rectal
  • Carrageenan
  • MIV-150
  • Zinc Acetate
  • Population Council
  • C1
  • HIV
  • HPV
  • HSV-2
  • NOV-1003 MPT in Development Topical Gel-Vaginal P1
  • HIV
  • HSV-2
  • Pregnancy
  • Origami Female Condom MPT in Development Barrier without Drug Condom-Female
  • Silicone
  • Strata Various Product Design
  • C3
  • Chlamydia
  • Gonorrhea
  • HIV
  • HSV-2
  • Pregnancy
  • poly-[1,4-phenylene-(1-carboxy) methylene] (PPCM) SAMMA Gel MPT in Development Topical Gel-Vaginal
  • poly-[1,4-phenylene-(1-carboxy) methylene
  • Yaso Biotechnologies
  • P1
  • Chlamydia
  • Gonorrhea
  • HIV
  • HPV
  • HSV-2
  • Pregnancy
  • SILCS (Caya®) Diaphragm + MIV-150 and zinc acetate in a carrageenan Gel (MZC gel; PC-1005) MPT in Development Barrier with Drug Diaphragm
  • Carrageenan
  • MIV-150
  • Zinc Acetate
  • CONRAD
  • Kessel
  • PATH
  • Population Council
  • P2
  • HIV
  • HPV
  • HSV-2
  • Pregnancy
  • SR-2P Gel MPT in Development Topical Gel-Vaginal
  • Acyclovir
  • SR-2P (Bioadhesive Polymer Gel)
  • Tenofovir (TFV)
  • SRI International
  • P1
  • HIV
  • HSV-2
  • Tenofovir + IQP-0528 MPT in Development Topical Intravaginal Ring (IVR)
  • IQP-0528
  • Tenofovir (TFV)
  • ImQuest BioSciences
  • P2
  • HIV
  • HSV-2
  • Tenofovir + Levonorgestrel IVR MPT in Development Topical Intravaginal Ring (IVR)
  • Levonorgestrel
  • Tenofovir (TFV)
  • CONRAD
  • C1
  • HIV
  • HSV-2
  • Pregnancy
  • Tenofovir Disoproxil Fumarate (TDF) IVR MPT in Development Topical Intravaginal Ring (IVR)
  • Tenofovir Disoproxil Fumarate (TDF)
  • Albert Einstein College of Medicine
  • C1
  • HIV
  • HSV-2
  • Tenofovir Film MPT in Development Topical Film - Vaginal
  • Tenofovir (TFV)
  • CONRAD
  • University of Pittsburgh
  • C1
  • HIV
  • HSV-2
  • Tenofovir IVR MPT in Development Topical Intravaginal Ring (IVR)
  • Tenofovir (TFV)
  • CONRAD
  • C1
  • HIV
  • HSV-2
  • Tenofovir Vaginal Insert MPT in Development Topical Fast Dissolve Insert/Capsule-Vaginal
  • Tenofovir (TFV)
  • CONRAD
  • C1
  • HIV
  • HSV-2
  • TFV + Acyclovir + Ethinyl Estradiol + Etonogestrel IVR MPT in Development Topical Intravaginal Ring (IVR)
  • Acyclovir
  • Ethinyl Estradiol
  • Tenofovir (TFV)
  • Auritec Pharmaceuticals
  • Oak Institute of Science
  • P2
  • HIV
  • HSV-2
  • Pregnancy
  • TFV/FTC Vaginal Insert MPT in Development Topical Fast Dissolve Insert/Capsule-Vaginal
  • Emtricitabine (FTC)
  • Tenofovir (TFV)
  • CONRAD
  • C1
  • HIV
  • HSV-2
  • VivaGel® MPT in Development Topical Gel-Vaginal
  • SPL7013 (Sulphonated Dendrimer)
  • StarPharma Holdings Limited
  • P2
  • Bacterial Vaginosis (BV)
  • HIV
  • HSV-2
  • Zinc acetate and carrageenan IVR (ZC IVR) MPT in Development Topical Intravaginal Ring (IVR)
  • Carrageenan
  • Zinc Acetate
  • Population Council
  • P2
  • HIV
  • HPV
  • HSV-2
  • IMPT Secretariat
    308 Natoma Street
    Suite 150
    Folsom, CA 95630
    916-932-4785 | This email address is being protected from spambots. You need JavaScript enabled to view it.

    © Copyright 2016, The IMPT. All rights reserved.

    The Initiative for Multipurpose Prevention Technologies (IMPT) is a project of CAMI Health, an organization dedicated women’s reproductive health and empowerment. CAMI Health is housed at the Public Health Institute (PHI).